VC
BOLT icon

Vivo Capital’s Bolt Biotherapeutics BOLT Stock Holding History

Vivo Capital’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$293K Hold
72,414
– – 0.02% 45
2025
Q4 		$396K Sell
72,414
-103,650
-59% -$556K 0.03% 46
2025
Q3 		$937K Hold
176,064
– – 0.08% 46
2025
Q2 		$986K Sell
176,064
-1
-0% -$7 0.1% 41
2025
Q1 		$1.41M Hold
176,065
– – 0.19% 36
2024
Q4 		$1.88M Hold
176,065
– – 0.21% 36
2024
Q3 		$2.28M Hold
176,065
– – 0.19% 35
2024
Q2 		$2.64M Hold
176,065
– – 0.24% 34
2024
Q1 		$4.93M Hold
176,065
– – 0.39% 35
2023
Q4 		$3.94M Sell
176,065
-17,500
-9% -$341K 0.32% 38
2023
Q3 		$4.03M Hold
193,565
– – 0.44% 37
2023
Q2 		$4.96M Hold
193,565
– – 0.34% 36
2023
Q1 		$5.38M Hold
193,565
– – 0.37% 33
2022
Q4 		$5.03M Hold
193,565
– – 0.58% 34
2022
Q3 		$5.73M Hold
193,565
– – 0.63% 36
2022
Q2 		$7.9M Hold
193,565
– – 0.79% 28
2022
Q1 		$10.6M Hold
193,565
– – 0.73% 29
2021
Q4 		$19M Hold
193,565
– – 1.14% 21
2021
Q3 		$49M Hold
193,565
– – 2.2% 11
2021
Q2 		$59.9M Hold
193,565
– – 2.59% 10
2021
Q1 		$127M Buy
+193,565
New +$126M 4.48% 8

Other funds holding BOLT

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM

Vivo Capital's BOLT Position: Q1 2026 in Review

Vivo Capital held its Bolt Biotherapeutics (BOLT) position steady in Q1 2026 at 72,414 shares worth $293K. The position accounts for 0.02% of the portfolio, ranked #45.

Vivo Capital first reported a position in BOLT in Q1 2021 and has held it in 21 quarters since. The position peaked at $127M in Q1 2021. 24 funds tracked by Wall St. Rank hold BOLT as of Q1 2026.

  • Vivo Capital held 72,414 shares of Bolt Biotherapeutics worth $293K as of Q1 2026.
  • Vivo Capital left its Bolt Biotherapeutics share count unchanged in Q1 2026.
  • Bolt Biotherapeutics made up 0.02% of Vivo Capital's portfolio in Q1 2026, its #45 holding.
  • Vivo Capital first reported a position in Bolt Biotherapeutics in Q1 2021 and has held it in 21 quarters since.
  • Vivo Capital's Bolt Biotherapeutics position peaked at $127M in Q1 2021.
  • 24 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q1 2026.

Based on Vivo Capital's 13F filing for Q1 2026, filed 15 May 2026.